Marik Covid Protocol Summary
Marik Covid Protocol Summary
Marik Covid Protocol Summary
Please refer to the full protocol for optional treatments and explanations. TRY TO AVOID INTUBATION IF POSSIBLE
(updated 10-29-2020)
Low-Flow Nasal Cannula
Prophylaxis ■ Typically set at 1-6 Liters/Min
■ Vitamin C 500 mg BID and Quercetin 250 mg daily
B complex vitamins
High Flow Nasal Cannula
■
■ Zinc 30-50 mg/day ■ Accept permissive hypoxemia (O2 Saturation > 86%)
■ Melatonin (slow release): Begin with 0.3mg and increase as tolerated to 2 mg ■ Titrate FiO2 based on patient’s saturation
at night
■ Accept flow rates of 60 to 80 L/min
■ Vitamin D3 1000-3000 u/day
■ Trial of inhaled Flolan (epoprostenol)
■ Ivermectin for postexposure prophylaxis and weekly prophylaxis in high risk groups
(150-200 ug/kg) ■ Attempt proning (cooperative proning)
Deterioration
Mildly Symptomatic patients (at home):
Invasive Mechanical Ventilation
Recovery
■ Ivermectin 150-200 ug/kg daily for two doses
■ Target tidal volumes of ~6 cc/kg
■ Vitamin C 500mg BID and Quercetin 250-500 mg BID
■ Lowest driving pressure and PEEP
■ Vitamin D3 2000 - 4000 u/day
■ Sedation to avoid self-extubation
■ B Complex vitamins
■ Trial of inhaled Flolan
■ Zinc 75-100 mg/day
■ Melatonin 6-10 mg at night (the optimal dose is unknown)
■ ASA aspirin 81-325 mg/day (unless contraindicated)
Prone Positioning
■ Exact indication for prone ventilation is unclear
In symptomatic patients, monitoring with home pulse oximetry is recommended.
Ambulatory desaturation below 94% should prompt hospital admission
■ Consider in patients with PaO2/FiO2 ratio < 150
Find the latest version at evms.edu/covidcare Developed and updated by Paul Marik, MD, Chief of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA